Drug regulator asks Serum Institute to increase safety monitors of Covid drug trials
Posted by
www.biotecnika.org
A day after the company halted the trial of the AstraZeneca-Oxford
University Covid vaccine in the country. The Drug controller has asked
the Pune based company to suspend any new recruitment in the Phase
II/III trial till further orders.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/drug-regulator-asks-serum-institute-to-increase-safety-monitors-of-covid-drug-trials/articleshow/78075468.cms
Subscribe to:
Post Comments (Atom)
Post a Comment